Evidence map›Paper›PMID 41554528›Full record

ArticleJournal of peptide science : an official publication of the European Peptide Society2026

A Novel Cell-Penetrating Lipopeptide for DNA Binding, Self-Assembly, and Delivery Into HeLa and Pluripotent Stem Cells.

Lucas R de Mello, Tâmisa Seeko Bandeira Honda, Valeria Castelletto, Patrícia Terra Alves, Sang Won Han, Emerson Rodrigo da Silva, Ian W Hamley

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of peptide science : an official publication of the European Peptide Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. A Novel Cell-Penetrating Lipopeptide for DNA Binding, Self-Assembly, and Delivery Into HeLa and Pluripotent Stem Cells.Journal of peptide science : an official publication of the European Peptide Society · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lucas R de MelloSchool of Chemistry, Food Biosciences and Pharmacy, University of Reading, Reading, UK.
Tâmisa Seeko Bandeira HondaDepartment of Immunology, Institute of Biomedical Science, University of São Paulo, São Paulo, São Paulo, Brazil.
Valeria CastellettoSchool of Chemistry, Food Biosciences and Pharmacy, University of Reading, Reading, UK.ORCID https://orcid.org/0000-0002-3705-0162
Patrícia Terra AlvesDepartamento de Biophysics, Federal University of São Paulo- Vila Clementino, São Paulo, São Paulo, Brazil.
Sang Won HanDepartamento de Biophysics, Federal University of São Paulo- Vila Clementino, São Paulo, São Paulo, Brazil.
Emerson Rodrigo da SilvaDepartamento de Biophysics, Federal University of São Paulo- Vila Clementino, São Paulo, São Paulo, Brazil.ORCID https://orcid.org/0000-0001-5876-2276
Ian W HamleySchool of Chemistry, Food Biosciences and Pharmacy, University of Reading, Reading, UK.ORCID https://orcid.org/0000-0002-4549-0926

Funding

Engineering and Physical Sciences Research Council EP/V053396/1Fundação de Amparo à Pesquisa do Estado de São Paulo 19/20907-7Fundação de Amparo à Pesquisa do Estado de São Paulo 2019/19719-1Fundação de Amparo à Pesquisa do Estado de São Paulo 2021/10092-6
6 · The paper itself

Abstract

A lipopeptide is designed that contains an epitope from simian virus T-antigen (SV40T, PKKKRKV) conjugated to an N-terminal palmitoyl (C

Indexed as

Cell-Penetrating PeptidesDNALipopeptidesPluripotent Stem CellsAnimalsHeLa CellsHumansMiceCell-Penetrating PeptidesDNALipopeptides

Identifiers

PMID41554528
PMCPMC12815588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.